These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11261586)

  • 21. Biological activity and receptor binding characteristics to various human tumors of acetylated somatostatin analogs.
    Pinski J; Milovanovic S; Yano T; Hamaoui A; Radulovic S; Cai RZ; Schally AV
    Proc Soc Exp Biol Med; 1992 May; 200(1):49-56. PubMed ID: 1349189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory and stimulatory effects of somatostatin on two human pancreatic cancer cell lines: a primary role for tyrosine phosphatase SHP-1.
    Douziech N; Calvo E; Coulombe Z; Muradia G; Bastien J; Aubin RA; Lajas A; Morisset J
    Endocrinology; 1999 Feb; 140(2):765-77. PubMed ID: 9927304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of neuronal nitric-oxide synthase activity by somatostatin analogs following SST5 somatostatin receptor activation.
    Cordelier P; Estève JP; Najib S; Moroder L; Vaysse N; Pradayrol L; Susini C; Buscail L
    J Biol Chem; 2006 Jul; 281(28):19156-71. PubMed ID: 16690617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiproliferative and GH-inhibitory activity of chimeric peptides consisting of GHRP-6 and somatostatin.
    Dasgupta P; Singh AT; Mukherjee R
    Biochem Biophys Res Commun; 1999 Jun; 259(2):379-84. PubMed ID: 10362518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Somatostatin activation of mitogen-activated protein kinase via somatostatin receptor 1 (SSTR1).
    Florio T; Yao H; Carey KD; Dillon TJ; Stork PJ
    Mol Endocrinol; 1999 Jan; 13(1):24-37. PubMed ID: 9892010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase.
    Liebow C; Reilly C; Serrano M; Schally AV
    Proc Natl Acad Sci U S A; 1989 Mar; 86(6):2003-7. PubMed ID: 2564678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human pancreatic cancer cell lines do not express receptors for somatostatin.
    Gillespie J; Poston GJ; Schachter M; Guillou PJ
    Br J Cancer; 1992 Sep; 66(3):483-7. PubMed ID: 1355659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dephosphorylation of cancer protein by tyrosine phosphatases in response to analogs of luteinizing hormone-releasing hormone and somatostatin.
    Lee LT; Schally AV; Liebow C; Lee PP; Lee PH; Lee MT
    Anticancer Res; 2008; 28(5A):2599-605. PubMed ID: 19035284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting peptides for pleural cavity tumor radiotherapy: specificity and dosimetry of Re-188-RC-160.
    Zamora PO; Bender H; Knapp FF; Rhodes BA; Biersack HJ
    Hybridoma; 1997 Feb; 16(1):85-91. PubMed ID: 9085134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effects of somatostatin analogues on proliferation of murine colonic cancer cells in vitro.
    Pawlikowski M; Kunert-Radek J; Winczyk K
    Cytobios; 1997; 89(358-359):183-7. PubMed ID: 9418016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor.
    Plonowski A; Schally AV; Letsch M; Krupa M; Hebert F; Busto R; Groot K; Varga JL
    Prostate; 2002 Aug; 52(3):173-82. PubMed ID: 12111694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular mechanisms of antiproliferative effect of somatostatin: involvement of a tyrosine phosphatase.
    Lopez F; Estève JP; Buscail L; Delesque N; Saint-Laurent N; Vaysse N; Susini C
    Metabolism; 1996 Aug; 45(8 Suppl 1):14-6. PubMed ID: 8769371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of the growth of Caki-I human renal adenocarcinoma in vivo by luteinizing hormone-releasing hormone antagonist Cetrorelix, somatostatin analog RC-160, and bombesin antagonist RC-3940-II.
    Jungwirth A; Schally AV; Halmos G; Groot K; Szepeshazi K; Pinski J; Armatis P
    Cancer; 1998 Mar; 82(5):909-17. PubMed ID: 9486581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin.
    Nagy A; Schally AV; Halmos G; Armatis P; Cai RZ; Csernus V; Kovács M; Koppán M; Szepesházi K; Kahán Z
    Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1794-9. PubMed ID: 9465096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of gastrointestinal hormones and synthetic analogues on the growth of pancreatic cancer.
    Robertson JF; Watson SA; Hardcastle JD
    Int J Cancer; 1995 Sep; 63(1):69-75. PubMed ID: 7558455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the antiproliferative signal mediated by the somatostatin receptor subtype sst5.
    Cordelier P; Estève JP; Bousquet C; Delesque N; O'Carroll AM; Schally AV; Vaysse N; Susini C; Buscail L
    Proc Natl Acad Sci U S A; 1997 Aug; 94(17):9343-8. PubMed ID: 9256484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-intensity p38 kinase activity is critical for p21(cip1) induction and the antiproliferative function of G(i) protein-coupled receptors.
    Alderton F; Humphrey PP; Sellers LA
    Mol Pharmacol; 2001 May; 59(5):1119-28. PubMed ID: 11306695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A somatostatin analogue inhibits MAP kinase activation and cell proliferation in human neuroblastoma and in human small cell lung carcinoma cell lines.
    Cattaneo MG; Amoroso D; Gussoni G; Sanguini AM; Vicentini LM
    FEBS Lett; 1996 Nov; 397(2-3):164-8. PubMed ID: 8955339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of epidermal growth factor and analogues of luteinizing hormone-releasing hormone and somatostatin on phosphorylation and dephosphorylation of tyrosine residues of specific protein substrates in various tumors.
    Lee MT; Liebow C; Kamer AR; Schally AV
    Proc Natl Acad Sci U S A; 1991 Mar; 88(5):1656-60. PubMed ID: 1672042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.
    Siehler S; Nunn C; Zupanc GK; Hoyer D
    Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.